Chondrodysplasia punctata with steroid sulfatase deficiency

Chondrodysplasia Punctata with Steroid Sulfatase Deficiency is a rare genetic disorder characterized by specific bone abnormalities and skin changes. This condition is part of a group of diseases known as chondrodysplasia punctata (CDP), which are marked by the presence of punctate calcifications within the cartilage. The variant associated with steroid sulfatase deficiency is also linked to X-linked ichthyosis, due to the shared genetic basis.

Etiology

The disorder is caused by mutations in the STS gene, which encodes the enzyme steroid sulfatase. This enzyme is crucial for the metabolism of cholesterol sulfate and steroids. The deficiency in steroid sulfatase activity leads to the accumulation of cholesterol sulfate in the skin, resulting in the ichthyosis phenotype, and affects the normal development of cartilage and bone.

Genetics

Chondrodysplasia punctata with steroid sulfatase deficiency is inherited in an X-linked recessive manner. This means the defective gene is located on the X chromosome. Males, having only one X chromosome, are more severely affected if they inherit the defective gene. Females, with two X chromosomes, are typically carriers and may show milder symptoms due to X-inactivation.

Clinical Features

The clinical manifestations of this condition include:

• Ichthyosis, which is a disorder characterized by dry, scaly skin.
• Short stature.
• Characteristic facial features, such as a flat nasal bridge.
• Punctate calcifications in the cartilage, particularly noticeable in the knees, hips, and hands.
• Cataracts or other eye abnormalities may also be present.

Diagnosis

Diagnosis of chondrodysplasia punctata with steroid sulfatase deficiency is based on clinical examination, radiographic findings of punctate calcifications, and genetic testing confirming a mutation in the STS gene. Prenatal diagnosis may be available for families with a known history of the condition.

Treatment

There is no cure for chondrodysplasia punctata with steroid sulfatase deficiency. Treatment is symptomatic and supportive. Management may include:

• Dermatological treatments for ichthyosis.
• Orthopedic interventions for skeletal abnormalities.
• Regular eye examinations and treatment for cataracts.

Prognosis

The prognosis for individuals with chondrodysplasia punctata with steroid sulfatase deficiency varies. The severity of symptoms can range widely, even among affected individuals within the same family. Early intervention and supportive care can improve the quality of life.

Chondrodysplasia punctata with steroid sulfatase deficiency Resources
Latest articles Most recent articles Ongoing trials	Wikipedia